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Abstract
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Few studies have simultaneously evaluated delay discounting and behavioral economic demand to
determine their unique contribution to drug use. A recent study in cannabis users found that
monetary delay discounting uniquely predicted cannabis dependence symptoms, whereas cannabis
demand uniquely predicted use frequency. This study sought to replicate and extend this research
by evaluating delay discounting and behavioral economic demand measures for multiple
commodities and including a use quantity measure. Amazon.com’s Mechanical Turk was used to
sample individuals reporting recent cannabis use (n = 64) and controls (n = 72). Participants
completed measures of monetary delay discounting as well as alcohol and cannabis delay
discounting and demand. Cannabis users and controls did not differ on monetary delay discounting
or alcohol delay discounting and demand. Among cannabis users, regression analyses indicated
that cannabis delay discounting uniquely predicted use severity, whereas cannabis demand
uniquely predicted use frequency and quantity. These effects remained significant after controlling
for other delay discounting and demand measures. This research replicates previous outcomes
relating delay discounting and demand with cannabis use and extends them by accounting for the
contribution of multiple commodities. This research also demonstrates the ability of online
crowdsourcing methods to complement traditional human laboratory techniques.
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1. Introduction

Author Manuscript

The marriage of behavioral economics with substance use research over the last three
decades has advanced an understanding of the etiology and treatment of drug-taking
behavior (Bickel et al., 2000; Chivers and Higgins, 2012; Hursh, 1984; MacKillop, 2016).
Two of the most common applications of behavioral economics to drug use are delay
discounting and behavioral economic demand. Delay discounting is the systematic reduction
in value of a reinforcer as a function of the delay to its delivery (Green and Myerson, 2004;
Odum, 2011; Rachlin and Green, 1972). Excessive delay discounting is thought central to
substance use disorders and may represent a trans-disease process relating drug use to other
maladaptive health behaviors (Bickel et al., 2012; Koffarnus et al., 2013). Several metaanalyses support this assertion by demonstrating a robust relationship between delayed
reward discounting and drug use severity, dependence, and quantity-frequency variables
(Amlung et al., 2016; MacKillop et al., 2011). This literature also provides evidence for an
association between delay discounting and treatment response across diverse clinical
populations (e.g., Krishnan-Sarin et al., 2007; MacKillop and Kahler, 2009; Washio et al.,
2011; Yoon et al., 2007).

Author Manuscript

Substance use researchers have also situated drug use within a commodity purchase
framework and used behavioral economic demand models to describe drug-taking behavior
(e.g., Hursh, 1984, 1993; Johnson and Bickel, 2006). A recent popular extension of these
methods is the commodity purchase task in which participants report hypothetical or
realized commodity consumption across a range of prices per unit of the commodity (Jacobs
and Bickel, 1999; MacKillop et al., 2008; Murphy et al., 2009). To date, purchase tasks have
been successfully applied to a variety of drugs and drug classes, including alcohol, cannabis,
cigarettes, cocaine, opioids, and synthetic cathinones (Amlung and MacKillop, 2015; Aston
et al., 2015, 2016; Bruner & Johnson, 2014; Collins et al., 2014; Johnson and Johnson,
2014; MacKillop et al., 2008; Murphy & MacKillop, 2006; Pickover et al., 2016). These
studies have demonstrated that commonly used and misused substances follow the same
prototypic patterns of consumption as other goods, including decreases in consumption with
increases in price, and price ranges at which consumption is sensitive (i.e., elastic) or
insensitive (i.e., inelastic) to price change. Such research has also helped reveal behavioral
mechanisms by which putative interventions may decrease drug consumption (Bujarski et
al., 2012; McClure et al., 2013) and prognostic variables predicting treatment success
(MacKillop and Murphy, 2007; Murphy et al., 2015).

Author Manuscript

Despite being the most widely used illicit substance in the United States, cannabis has
received comparatively little attention in the delay discounting and demand literatures.
Further information on cannabis delay discounting and demand could be useful given the
increasing number of states proposing or that have passed legalized recreational use, and the
growing prevalence of cannabis use reported in the United States over the last decade
(Center for Behavioral Health Statistics, 2016). Although many first-time or recreational
users will not continue to regular use, others will progress to problematic usage patterns and
seek treatment for cannabis use disorder. The application of behavioral economic theory
could help identify behavioral mechanisms contributing to maladaptive use and hasten the
design of preventative and therapeutic interventions.
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The association between delay discounting and cannabis use is more variable than for other
drugs. For example, several studies have failed to show significant differences in delay
discounting rates between cannabis users and controls (Johnson et al., 2010) or a
relationship between delay discounting and treatment outcomes (Heinz et al., 2013; Peters et
al., 2013; but see Stanger et al., 2012). However, others have demonstrated a role for delay
discounting in aspects of cannabis use with significant associations observed between delay
discounting and cannabis use initiation and severity (Aston et al., 2016; Bidwell et al., 2013;
Heinz et al., 2013; Kollins, 2003). These differences in experimental outcomes could stem
from the variations in the questions posed, namely delay discounting in cannabis users
compared to controls as opposed to correlations between delay discounting and features of
cannabis use (e.g., use severity). This limited literature also displays heterogeneity with
respect to sample characteristics (e.g., college students versus treatment samples), delay
discounting measures, and the commodity discounted. Such heterogeneity underscores the
need for additional research to evaluate the association between delay discounting and
aspects of cannabis, and to compare delay discounting rates between cannabis users and
controls.
Cannabis demand has received even less attention than delay discounting, representing a
research literature in its infancy. The few extant studies have revealed outcomes consistent
with previous work with other drugs, such as a sensitivity of cannabis demand to increased
cost and an expected relationship between cannabis demand and measures of cannabis use
severity and frequency (Aston et al., 2015; Collins et al., 2014). These studies have also
demonstrated changes in cannabis demand following manipulations affecting state
disposition, with increases observed in cannabis demand after cannabis-cue presentation
(Metrik et al., 2016).

Author Manuscript
Author Manuscript

Recent attempts have been made to unify the ideas of delay discounting and demand under a
broader “reinforcer pathology” conceptualization of substance use (Bickel et al., 2011). This
approach posits that substance use disorders are characterized by an extreme preference for
immediate consumption of a drug reinforcer (i.e., delay discounting) combined with high
valuation of that reinforcer (i.e., behavioral economic demand). Relatively little research,
however, has simultaneously evaluated demand and delay discounting metrics despite their
mutual importance for this and other theoretical models. In fact, only one study has done so
in the context of cannabis use (Aston et al., 2016). Data in that study were combined from
participants completing a delay discounting task for money following placebo smoked
cannabis administration and a purchase task for hypothetical cannabis completed during a
baseline screening session. Delay discounting and behavioral economic demand functioned
as independent predictors, with monetary delay discounting uniquely predicting cannabis
dependence (CD) symptom count and cannabis demand uniquely predicting frequency of
cannabis use. However, this previous study only evaluated monetary delay discounting and
cannabis demand. The inclusion of delay discounting and demand measures for multiple
drug commodities (e.g., cannabis, alcohol) would help to demonstrate the specificity of
cannabis-relevant outcomes for predicting use behaviors.
The purpose of the present study was to replicate and extend those findings relating delay
discounting and demand to cannabis use behaviors. To this end, Amazon.com’s Mechanical
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Turk (mTurk) was used to sample individuals reporting recent cannabis use. This study
sought to extend previous research by 1) using an alternative sampling method allowing for
greater demographic and drug use variability, 2) evaluating multiple commodities for delay
discounting and demand variables, and 3) including a measure of use quantity (i.e., grams
used per week) to further describe cannabis use patterns. Cannabis delay discounting was
expected to uniquely predict CD symptom count and cannabis demand was expected to
uniquely predict frequency and quantity of cannabis use. Alcohol delay discounting and
demand were not expected to relate to cannabis use behaviors. As a secondary analysis,
measures of delay discounting and behavioral economic demand were compared between
cannabis users and non-cannabis using controls to add to the limited literature evaluating
these outcomes between these groups. Significant differences between cannabis users and
controls were not expected.

Author Manuscript

2. Methods
2.1 Participants and Procedures

Author Manuscript

Participants were sampled using mTurk where tasks are advertised as Human Intelligence
Tasks (HITs). Participants were required to have a 95% or higher approval rating on all
previously submitted mTurk HITs, over 100 approved HITs, and current residence in the
United States to view the study HIT. The accuracy of these inclusion criteria was verified by
the mTurk platform. Participants reviewed an informed consent document describing the
study procedures, compensation, and the fact that anonymity would be retained throughout
the study. All respondents indicated by electronic confirmation that they understood this
document and agreed to participate. The University of Kentucky Institutional Review Board
approved all protocols, including the consent process, and the protocol was carried out in
accordance with the Declaration of Helsinki.

Author Manuscript

Participants completed the study tasks as a part of larger study on choice and decisionmaking. A short screening questionnaire was used to determine if participants qualified for
this study. Participants were only able to complete the screener once. Eligible participants
were individuals reporting cannabis use during the past two weeks and 50 or more lifetime
uses (n = 78). An additional control group was used to compare behavioral economic
demand and delay discounting outcomes and included participants who did not report
cannabis use in the past two weeks and five or fewer lifetime uses (n = 86). All participants
were 18 years of age or older. Four attention checks were used to identify non-systematic,
inattentive, or inconsistent participant data: 1) comparison of age and sex responses at the
start and end of the survey, 2) recall at the end of the survey of a single digit number
presented halfway through that participants were instructed to remember, 3) an item that
instructed participants to select a specific response (i.e., “Select ‘A Little Bit’”), and 4) an
item that asked participants if they had been attentive and thought their data should be
included. Participants failing one or more checks were removed from data analysis, which
resulted in a final sample size of 136 participants (cannabis users = 64; controls = 72).
Demographic and drug use variables for cannabis users and controls are presented in Table
1.
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2.2.1 5-Trial Adjusting Delay Task—A 5-trial adjusting delay task was used to evaluate
delay discounting rates (for details see Koffarnus and Bickel, 2014). This task has been
previously validated against traditional adjusting amount delay discounting tasks (Cox and
Dallery, 2016; Koffarnus and Bickel, 2014). Participants were asked to select between some
amount of a delayed commodity and half that amount available immediately. The delayed
and immediate amounts remained constant while the delay to the larger amount was adjusted
after each choice. The first choice was always at a three-week delay, which then adjusted up
(longer delay following delayed choice) or down (shorter delay following immediate choice)
based on decisions. The ED50, the inverse of the delay discounting rate or k, was determined
following five choices and included 32 potential values between 1 hour and 25 years. The
benefits of this 5-trial task include rapid assessment of delay discounting rates and minimal
computing requirements. These advantages are particularly important given the online
research context wherein time is limited and data collection is constrained by the
participant’s computer equipment.

Author Manuscript

Participants completed up to three different versions of the task. All participants completed a
traditional monetary delay task, with $1000 available delayed versus $500 available now. All
cannabis-using participants also completed a cannabis delay discounting task, with 1 ounce
of typical quality cannabis available delayed versus ½ ounce available now. Any participant
endorsing current alcohol use also completed an alcohol delay task, with 24 US standard
drinks available delayed versus 12 drinks available now (standard drink: one 12 oz. beer, 5
oz. wine, or 1.5 oz. shot/mixed drink). These commodity amounts were within ranges used
in previous alcohol and cannabis delay discounting studies (Johnson et al. 2010; Petry,
2001). All delay discounting tasks included a statement emphasizing that consumption was
not constrained by time and that the hypothetical goods could be kept.

Author Manuscript

2.2.2 Commodity Purchase Tasks—Commodity purchase tasks were used to evaluate
behavioral economic demand for cannabis and alcohol. The same scenario was used in each
task and all purchasing situations were framed as hypothetical in the present tense.
Participants were asked to imagine a typical day over the last month when they used the
commodity. They were told that they could only get the commodity from this source, had no
commodity saved or kept from previous days, could not stockpile, and would have to
consume all purchases in a single day. Participants were then asked how many drinks
(alcohol) or hits (cannabis) they would purchase at 13 monetary increments ranging from
$0.00 [free] to $11/unit, presented sequentially. This price range was selected due to its
similarity to price ranges used in recent commodity purchase task studies (Amlung et al.,
2015a; Aston et al., 2015, 2016; Murphy et al., 2015). Alcohol drinks were described as one
US standard drink. Cannabis hits were quantified as 0.09 g of average quality cannabis (i.e.,
10 hits = 1 joint or 0.9 g or 1/32nd of an ounce) consistent with previous literature (Aston et
al., 2015). All cannabis-using participants completed the commodity purchase task for
cannabis (Marijuana Purchase Task [MPT]; note the term Marijuana Purchase Task [MPT] is
used to avoid confusion with the commonly used Cigarette Purchase Task [CPT]) and all
participants endorsing current alcohol use the task for alcohol (Alcohol Purchase Task;
APT).
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2.2.3 Drug Use Variables—A written version of the Mini-International Neuropsychiatric
Interview (MINI) was used to evaluate cannabis dependence (CD) through endorsement of
statements indicative of DSM-IV criteria (Sheehan et al., 1998). A Cannabis History and
Smoking Questionnaire included questions about age of use onset, cannabis use patterns,
and routes of administration (e.g., Aston et al., 2015; Metrik et al., 2009). Cannabis use
variables included use severity (number of DSM-IV CD symptoms endorsed), frequency
(percentage past month use days), and quantity (grams used per week), consistent with
previous delay and demand literature (Aston et al., 2016). Other relevant drug use variables
and demographics, such as age and the Fagerström Test for Nicotine Dependence (FTND),
were also measured.
2.3 Data Analysis

Author Manuscript

Delay discounting rates (k values) were calculated by taking the inverse of ED50 values
derived from the 5-trial adjusting delay task (Koffarnus and Bickel, 2014). Delay
discounting rates were log-transformed prior to analysis to obtain normality. Demand curves
were first evaluated for inattentive data or non-systematic curves using standard criteria (see
details in Stein et al., 2015). Briefly, curves were evaluated for increased consumption with
increased price, frequent price-to-price consumption increases, or reversals from zero
consumption as well as extreme consumption (i.e., greater than 100 drinks or hits [9 grams
of cannabis] in one day). Nine cannabis curves (14.1%) and 16 alcohol curves (15.7%) were
determined non-systematic/inattentive and removed from demand analysis. Price elasticity
and intensity were generated using the exponentiated demand equation:

Author Manuscript
Author Manuscript

where Q = consumption; Q0 = derived intensity of demand (consumption at zero price); k =
a constant that denotes consumption range in log units (a priori set to 2); C = the price of the
commodity; and α = derived elasticity of demand. The exponentiated model is a recently
developed and validated equation that allows for the inclusion of zero consumption values
(Koffarnus et al., 2015; Strickland et al., 2016b). Area under the curve (AUC) values were
also generated as described previously (Amlung et al., 2015b; Aston et al., 2016). Briefly,
the total area was operationalized as the AUC value when the maximum consumption value
across the sample was inputted for each price (100 for both the MPT and APT).
Proportionate AUC values were then generated by dividing each participants raw AUC by
this total AUC (range = 0.0 to 1.0). Recent reports have proposed AUC as a single demand
metric that is useful and valid measure to minimize repeated testing with multiple demand
metrics and to allow for convergence with other behavioral economic measures (Amlung et
al., 2015b; Aston et al., 2016). All demand metrics were log-transformed to correct for skew.
Demographic and drug use variables for cannabis users and controls were compared using
independent sample t-tests. Independent sample t-tests were also used to compare monetary
delay discounting as well as alcohol delay discounting and demand between groups. The
relationship between cannabis use and demographic, demand, and delay discounting
variables was first described using bivariate correlations in the cannabis-using group. The
independent contribution of demand and delay discounting for predicting cannabis use was
Behav Processes. Author manuscript; available in PMC 2018 July 01.
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then determined using multiple regression models. Consistent with previous studies (Aston
et al., 2016), AUC was first used to quantify demand in these analyses. Follow up analyses
were then conducted using demand intensity and elasticity in place of AUC. Additional tests
were also conducted controlling for age, sex, income, and cigarette use (given the close
association between cigarette use and delay discounting; Bickel et al., 1999; Johnson et al.,
2007). Only cannabis-using participants with all demand and delay discounting variables
were included in regression analysis (n = 46 with complete data). All tests were conducted
using SPSS 24 and GraphPad Prism 6.0 with a type I error rate of .05.

3. Results
3.1 Between-Group Comparisons

Author Manuscript

3.1.1 Demographics and Drug Use—Individuals reporting cannabis use were younger
and more likely to report recent cigarette and alcohol use (i.e., in the past two weeks).
Cannabis users also reported more drinking days per week and alcoholic drinks per week.
Other demographic variables (e.g., race, income) did not differ between groups (Table 1).
3.1.2 Delay Discounting—Raw monetary, cannabis, and alcohol delay discounting rates
are presented in Table 2. Monetary delay discounting did not differ between cannabis users
and control (t134 = 0.52, p = .60). Similarly, alcohol delay discounting did not differ between
these groups (t100 = 0.38, p = .70). No differences in the magnitude or significance of these
findings were observed after controlling for relevant covariates (e.g., age, cigarette use,
alcohol use).

Author Manuscript

3.1.3 Drug Demand—Demand curves for the MPT and APT showed prototypical
decreases in consumption with increases in price for both groups (Figure 1). The
exponentiated demand equation provided an excellent fit to group data (MPT: R2 = .99;
APT: Cannabis Users R2 = .98, Controls R2 = .98) as well as individual curves (MPT:
median R2 = .95, IQR = .91 to .97; APT: median R2 = .87, IQR = .79 to .93). No betweengroup differences were observed for alcohol AUC (t85 = 0.39, p = .70). Similarly, no
differences were observed for alcohol demand intensity (t85 = 0.50, p = .62) or elasticity (t85
= 0.51, p = .61). No changes in the magnitude or significance of these comparisons between
cannabis users and controls were observed in covariate analyses.
3.2 Drug Use Prediction in Cannabis Users

Author Manuscript

3.2.1 Bivariate Relationships—Bivariate relationships among drug demand, delay
discounting variables, and self-reported drug use in cannabis users are presented in Table 3.
Cannabis AUC was significantly and positively related to grams of cannabis used per week
(r = .45, p = .001), percentage past month use days (r = .31, p = .02), and number of CD
symptoms endorsed (r = .42, p = .001). Similar bivariate associations were observed for
cannabis demand intensity and elasticity (Supplemental Table 1). Cannabis delay
discounting was related to grams of cannabis used per week (r = .38, p = .002) and number
of CD symptoms endorsed (r = .44, p < .001).
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Intercorrelations between delay discounting and AUC revealed three significant associations
all involving cannabis delay discounting. Cannabis delay discounting was significantly and
positively related to cannabis demand (r = .34, p = .01), monetary delay discounting (r = .42,
p = .001), and alcohol delay discounting (r = .33, p = .01).

Author Manuscript

3.2.2 Regression Models—Results from three regression models evaluating the unique
prediction of cannabis use by AUC and delay discounting variables are presented in Table 4.
Cannabis delay discounting was uniquely associated with the number of CD symptoms
endorsed (sr2 = .16). The model predicting percentage of past month use days indicated a
significant independent effect of cannabis AUC (sr2 = .09), but not alcohol AUC or delay
discounting variables. A significant unique effect of cannabis AUC was also observed in the
model predicting grams of cannabis used per week (sr2 = .12). Models including additional
covariates (e.g., age, cigarette use) revealed outcomes similar in magnitude and significance.
Cannabis AUC by delay discounting interactions were not significant when tested.
Additional models were used to determine if the association between cannabis use behaviors
and behavioral economic demand was related to demand intensity (Q0) and/or elasticity (α).
Models including demand intensity and elasticity revealed a similar pattern of effects as the
AUC analysis, with cannabis demand intensity uniquely contributing to cannabis use
frequency and quantity and cannabis delay discounting uniquely contributing to use severity
(Table 5). Specifically, cannabis demand intensity was significantly and positively related to
use quantity (sr2 = .29) and frequency (sr2 = .19). Alcohol demand intensity also showed an
inverse relationship with grams of cannabis used per week (sr2 = .15).

4. Discussion
Author Manuscript
Author Manuscript

The primary finding of the present study was that cannabis delay discounting uniquely
predicted use severity (i.e., CD symptom count), whereas cannabis demand uniquely
predicted use frequency (i.e., past month use days) and quantity (i.e. grams used per week)
in regression models. Follow-up analyses indicated that the primary behavioral mechanism
contributing to the relationship between behavioral economic demand and cannabis use
frequency and quantity was demand intensity. These findings are consistent with the only
other study to evaluate the unique contribution of cannabis delay discounting and demand to
cannabis use behaviors (Aston et al., 2016). Several methodological concerns potentially
limited the generalizability of this aforementioned study, including the use of an exclusively
White sample, low prevalence of CD symptoms, and data collection following placebo
cannabis self-administration that may have influenced reported delay discounting outcomes
(see Metrik et al., 2009, 2012 for discussion of cannabis expectancies). Our findings suggest
that these experimental parameters did not contribute to the observed relationships and that
the unique contribution of delay discounting and demand to cannabis use outcomes likely
generalizes to diverse experimental settings and populations. Replication studies such as this
one are particularly important given recent challenges the psychological and behavioral
sciences have faced regarding reproducibility (Nosek et al., 2015; Open Source Data
Collection, 2015).
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A consistency across online and in-laboratory samples also strengthens the case for the use
of online sampling techniques to evaluate substance-using populations and behavioral
mechanisms related to drug use (Koffarnus et al., 2015; Rass et al., 2015; Strickland et al.,
2016a). The use of crowdsourcing comes with many benefits including increased geographic
and demographic variability, targeted recruitment of hard-to-reach populations, and a
relative cost and time efficiency. A requisite step for using crowdsourcing, however, is the
validation of findings across Internet and laboratory settings. This is particularly important
for addiction research given that drug use cannot be biologically verified in participants
online. The current study adds to the extant literature demonstrating similar outcomes across
in-laboratory and online samples (e.g., Johnson et al., 2015; Strickland et al., 2016a),
thereby supporting the validity of the crowdsourcing approach. These findings are
particularly exciting as they offer a method by which findings can be replicated across
diverse samples using sampling methods that provide complementary benefits and
limitations.

Author Manuscript

In addition to replicating associations involving cannabis demand and delay discounting in
this novel sample, this study extends previous findings in at least three ways. First, cannabis
and alcohol demand and delay discounting measures were used to determine if the observed
relationships were specific to cannabis. Alcohol was selected given the extensive literature
validating the alcohol purchase task, the common use of alcohol in the general population,
and the expectation that alcohol use should not uniquely associate with elevated cannabis
use frequency, quantity, or severity. Cannabis demand and delay discounting specifically
contributed to these cannabis use variables, even after controlling for the contribution of
another common drug commodity (i.e., alcohol). Alcohol demand intensity was related to
cannabis use quantity when testing demand intensity and elasticity measures; however, this
relationship was not observed at the bivariate level and was smaller than the relationship
involving cannabis demand intensity in the multiple regression model. Although monetary
delay discounting was related to CD symptom count at the bivariate level, consistent with
previous findings (Aston et al., 2016), the association was not unique or significant when
controlling for the cannabis commodity relationship. These outcomes indicate that these
behavioral economic relationships do not likely represent a general propensity to respond in
a non-specific manner to the task requirements. Instead, they suggest that these relationships
with drug use outcomes are specific to drug of interest, in this case cannabis.

Author Manuscript

Second, a quantity measure was included in addition to the frequency and severity measures
previously evaluated. Similar outcomes as the frequency measure were observed, wherein
cannabis demand uniquely predicted the quantity of cannabis use above and beyond other
demand and delay discounting measures. This distinction is important given that cannabis
use frequency and quantity represent unique dimensions of use patterns and can provide
unique prediction of cannabis-related problems (Zeisser et al., 2012). Third, the recently
developed 5-trial adjusting delay task was used, which allowed for rapid (~ 1 minute)
generation of delay discounting rates. Prior research has validated this task by revealing a
close relationship between this rapid task and traditional adjusting delay tasks (Cox and
Dallery, 2016; Koffarnus and Bickel, 2014). To our knowledge, this is the first use of drug
commodities, namely alcohol and cannabis, with this rapid delay discounting task. That the
relationship between monetary, alcohol, and cannabis delay discounting rates and drug use
Behav Processes. Author manuscript; available in PMC 2018 July 01.

Strickland et al.

Page 10

Author Manuscript

outcomes were generally significant and in the expected direction provides further support
for use of this rapid assessment task in substance use research. The more complex
relationships involving delay discounting (i.e., multiple regression analyses) were also
consistent with previous findings (Aston et al., 2016), further supporting the validity of this
delay discounting task and its future use.

Author Manuscript

Secondary analyses that focused on differences in delay discounting and demand variables
between cannabis-users and non-using controls were also conducted given the limited
research comparing these groups on these measures. Significant differences in monetary
delay discounting as a function of cannabis use status were not observed, although this
outcome is generally consistent with previous research (e.g., Johnson et al., 2010).
Differences in alcohol delay discounting or demand were also not detected among cannabis
users and controls. These outcomes remained after controlling for potentially important
covariates, such as age or cigarette use, suggesting that the failure to detect differences was
not due to low power or imbalances in relevant demographics. Taken together, these findings
suggest that alterations in delay discounting and demand may not capture between-group
differences in the likelihood of reporting current cannabis use. Instead, these measures may
reflect differences in the propensity to use cannabis in a maladaptive or clinically relevant
manner.
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These findings should be considered within the context of their limitations. First, a large
proportion of subjects were excluded due to inattentive or non-systematic data. This rate is
generally consistent with previous mTurk research (e.g., Johnson et al., 2015) but is a
limitation of conducting online research, and underscores the need to verify response fidelity
due to decreased experimental control. Second, all participants completed the demand
measures first followed by the delay discounting measures, and completed monetary delay
discounting prior to drug tasks. Although this non-random completion order did not likely
alter study outcomes, additional research would be needed for confirmation. Third, as noted
above, cannabis use in the cannabis-using group was not biologically verified. However, the
use of rigorous internal control measures and the consistency between this study and the
previous laboratory one (Aston et al., 2016) supports the integrity of the data collected and
outcomes reported. Fourth, participants were not asked about how much money they
typically spent on cannabis. Because participants reported 50 or more lifetime uses, they
were likely at least familiar with cannabis pricing. Fifth, the 5-trial delay discounting task
did not permit examination of underlying orderliness in the raw data like traditional delay
discounting tasks. However, the use of rigorous manipulation checks to evaluate participant
attention and response fidelity helped to offset this limitation. Despite these potential
limitations, this study replicates and extends previous research uniquely relating delay
discounting and behavioral economic demand variables with cannabis use. This study also
demonstrates the ability of online crowdsourcing to complement standard human laboratory
procedures, thereby enhancing the overall rigor of research methods used to examine
behavioral mechanisms of drug use disorders.
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Figure 1.
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Behavioral economic demand (left panels) and expenditure (right panels) for cannabis (top
panels) and alcohol (bottom panels). Participants completed commodity purchase tasks in
which hypothetical cannabis (one hit quantified as 0.09 g) or alcohol (one US standard
drink) were available. Price varied in United States dollars (USD). Plotted are mean (SEM)
group data on a log-log axis fit using the exponentiated model. Squares and solid lines
represent cannabis users (n = 55 for cannabis demand and 50 for alcohol demand) and
circles and the dotted lines represent controls (n = 37 for alcohol demand).
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Demographics and Drug Use Variables
Cannabis User (n = 64)

Control (n = 72)

Mean (SD)/%

Mean (SD)/%

p

Age

30.2 (7.3)

33.7 (9.9)

.02*

Male

48.4%

44.4%

.73

White

74.2%

75.0%

.99

Demographics

College Education

50.0%

65.3%

.08

Household Income

$41094 ($28122)

$43889 ($28756)

.57

100.0%

34.7%

-

Cannabis Use
Ever Use

Author Manuscript

Lifetime Use

5810 (21166)

0.8 (1.7)

-

63.7% (34.4%)

0%

-

Grams/Week

6.4 (7.1)

-

-

# CD Symptoms

2.0 (2.1)

-

-

60.9%

15.3%

.001***

3.9 (2.6)

4.0 (3.0)

.88

85.9%

59.7%

.001**

Drinks/Weekb

9.2 (14.4)

3.7 (7.8)

.03*

Drinking Days/Weekb

2.5 (2.0)

1.6 (1.4)

.01*

72.7%

41.9%

.003**

% Month Use Days

Other Drug Use
CIG Use
FTNDa
ALC Use

Heavy Use Daysb

Author Manuscript

Note. CIG Use = cigarette use in the past two weeks determined from study screener; ALC Use = alcohol use in the past two weeks determined
from study screener; # CD Symptoms = number of cannabis use dependence symptoms endorsed; FTND = Fagerström Test for Nicotine
Dependence; Heavy Use Days = number of past month heavy alcohol use days (5 or more [males] or 4 or more [females] drinks in a single day).

a
Variable only for participants reporting cigarette use in the past two weeks (n = 39 Cannabis Users; n = 11 Controls)
b

Variable only for participants reporting alcohol use in the past two weeks (n = 55 Cannabis Users; n = 43 Controls)

*

p < .05;

**

p < .01;

***

p < .001

Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript

Mean (SD)

.02 (.02)

Alcohol

7.0 (8.7)

Alcohol

.061 (.138)

Alcohol

.97 (3.79)

3.83 (7.97)

Cannabis

Alcohol

59

64

64

50

55

50

55

50

55

n

3.90 (8.59)

-

.02 (.05)

.027 (.047)

-

7.7 (16.8)

-

.02 (.01)

-

Mean (SD)

43

-

72

37

-

37

-

37

-

n

Control (N = 72)

.70

-

.60

.61

-

.62

-

.70

-

p

discounting rate from 5-trial adjusting delay discounting task. Raw values are presented for descriptive purposes; all data were log-transformed for normality prior to analysis.

Note. AUC = area under the curve from purchase task data; Q0= demand intensity from the exponentiated demand equation; α = demand elasticity from the exponentiated demand equation; k = delay

.02 (.06)

Money

Delay Discounting (k)

.028 (.047)

Cannabis

Demand (α)

35.6 (32.5)

Cannabis

Demand (Q0)

.04 (.08)

Cannabis

Demand (AUC)

Variable

Cannabis User (N = 64)

Drug Behavioral Economic Demand and Delay Discounting in Cannabis Users and Controls

Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript
.07

Alcohol (n = 50)

.01
.04

Cannabis (n = 64)

Alcohol (n = 59)

−.01

.06

−.11

−.14

−.01

Male

−.02

−.07

−.22

.04

.10

Income

−.17

−.03
.07

.38**

.44**
.12

.24

.00

.45**

Grams/Week

.27*

.02

.38**

−.03

.42**

CD Count

.08

Alcohol Heavy

−.10

.04

.10

.11

.31*

Month Use

−.08

.34*

.20

.25

-

CAN

.01

.22

.15

-

-

ALC

Demand

.18

.42**

-

-

-

MON

-

.33*

-

-

-

ALC

-

-

-

-

CAN

Delay Discounting

p < .01

p < .05;

**

*

Note. CAN = Cannabis; ALC = alcohol; MON = money; AUC = area under the curve from purchase task data; k = delay discounting rate from 5-trial adjusting delay discounting task; Alcohol Heavy = past
month heavy alcohol use days (5 or more [males] or 4 or more [females] drinks in a single day): CD Count = number of cannabis use dependence symptoms endorsed; Month Use = percentage past month
cannabis use days. n = 64 cannabis users, sample sizes included in the table vary for each measure due to self-reported use or rates of systematic data. Bold = significant at p < .05

−.16

Money (n = 64)

Delay Discounting (k)

.02

Cannabis (n = 55)

Demand (AUC)

Age

Cannabis Use

Correlations Among Behavioral Economic Demand, Delay Discounting, and Drug Use Variables

Author Manuscript
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−.13

Alcohol-k
−.10

−.17

.48

.21

.19

β

.01

.03

.16

.03

.03

sr2

.50

.21

.003**

.15

.18

p

.32

−.98

.18

3.70

.81

b

.09

−.12

.04

.39

.12

β

.01

.01

<.01

.12

.01

sr2

.58

.42
.02

.06

−.08

.23

.02*
.84

.03

b

.08

.10

−.22

.35

.06

β

<.01

.01

.03

.09

<.01

sr2
p

.66

.51

.22

.05*

.69

% Month Use Days

.46

p

Grams Cannabis/Week

p < .01

p < .05;

**

*

Note. AUC = area under the demand curve from purchase task data; k = discounting rate from 5-trial adjusting delay discounting task; % Month Use Days = percentage past month cannabis use days; # CD
Symptoms = number of cannabis use dependence symptoms endorsed. n = 46 cannabis users. Bold = significant at p < .05

−.52

Alcohol-AUC

.77

Cannabis-AUC

.93

.50

Money-k

Cannabis-k

b

Predictor

# CD Symptoms

Area Under the Demand Curve and Delay Discounting as Predictors of Cannabis Use Variables

Author Manuscript
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.87

.12

.55

−.13

Alcohol-Q0

Alcohol-α

Alcohol-k
−.10

.19

.03

.44

−.09

.24

.18

β

.01

.02

<.01

.13

.01

.04

.03

sr2

.49

.26

.88

.01**

.53

.12

.21

p

.18

−1.82

−6.64

−.20

−1.57

8.03

−.10

b

.05

−.24

−.52

−.04

−.16

.66

−.02

β

<.01

.03

.15

<.01

.02

.29

<.01

sr2

.70

.01

−.18

−.30

.002**
.14

−.10

.78

−.09

.46

.001***
.24

−.02

b

.91

p

Grams Cannabis/Week

.04

−.33

−.33

−.28

−.14

.53

−.04

β

<.01

.06

.06

.05

.01

.19

<.01

sr2
p

.78

.07

.09

.10

.40

.003**

.82

% Month Use Days

p < .001

***

p < .01;

p < .05;

**

*

Month Use Days = percentage past month cannabis use days; # CD Symptoms = number of cannabis use dependence symptoms endorsed. n = 46 cannabis users. Bold = significant at p < .05

Note. Q0= demand intensity from the exponentiated demand equation; α = demand elasticity from the exponentiated demand equation; k = discounting rate from 5-trial adjusting delay discounting task; %

−.35

1.14

Cannabis-Q0

Cannabis-k

.48

Money-k

Cannabis-α

b

Predictor

# CD Symptoms

Demand Intensity, Demand Elasticity, and Delay Discounting as Predictors of Cannabis Use Variables

Author Manuscript
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